Covered versus uncovered double bare self-expandable metal stent for palliation of unresectable extrahepatic malignant biliary obstruction: a randomized controlled multicenter trial

医学 支架 临床终点 危险系数 置信区间 随机对照试验 外科 胆囊炎 内科学 胆囊
作者
Se Woo Park,Kyong Joo Lee,Moon Jae Chung,Jung Hyun Jo,Hee Seung Lee,Jeong Youp Park,Seung Woo Park,Si Young Song,Huapyong Kang,Eui Joo Kim,Yeon Suk Kim,Jae Hee Cho,Seungmin Bang
出处
期刊:Gastrointestinal Endoscopy [Elsevier BV]
卷期号:97 (1): 132-142.e2 被引量:16
标识
DOI:10.1016/j.gie.2022.08.041
摘要

In a recent randomized controlled trial, a double bare metal stent (DBS) showed better stent patency than single-layer metal stents. However, clear evidence comparing the efficacy of uncovered (UCDBS) and partially covered (PCDBS) DBSs for distal malignant biliary obstruction (MBO) is lacking. Therefore, we compared the clinical outcomes including stent patency of UCDBSs versus PCDBSs.A multicenter, randomized study was performed in patients with distal MBO. The primary endpoint was stent patency. Secondary endpoints were the proportion of patients with patent stents at 6 months, risk factors for stent dysfunction, overall survival, technical and clinical success rates of stent placement, and other adverse events (AEs).Among 258 included patients, 130 were randomly assigned to the PCDBS group and 128 to the UCDBS group. The mean duration of stent patency of the PCDBS (421.2 days; 95% confidence interval [CI], 346.7-495.7) was longer than that of the UCDBS (377.4 days; 95% CI, 299.7-455.0), although total stent dysfunction and stent dysfunction within 6 months were not different between groups. Multivariate analysis indicated that chemotherapy after stent placement was a significant factor for overall survival (hazard ratio, .570; 95% CI, .408-.796) and had a marginal impact on stent patency (hazard ratio, 1.569; 95% CI, .923-2.667). There were no remarkable differences in AEs, including pancreatitis, cholecystitis, and stent migration, between the 2 groups.The use of PCDBSs compared with UCDBSs in patients with distal MBO has unclear benefits regarding stent patency and overall survival, although PCDBSs have a lower rate of tumor ingrowth. (Clinical trial registration number: NCT02937246.).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
高贵的铁身完成签到,获得积分10
刚刚
1秒前
1秒前
3秒前
4秒前
华仔的应助被科研通管家采纳,获得10
6秒前
6秒前
乐乐的应助被科研通管家采纳,获得30
6秒前
充电宝的应助被科研通管家采纳,获得10
6秒前
深情安青的应助被科研通管家采纳,获得10
7秒前
桐桐的应助被拥你入怀采纳,获得10
7秒前
无极微光的应助被科研通管家采纳,获得20
7秒前
852的应助被科研通管家采纳,获得10
7秒前
爆米花的应助被科研通管家采纳,获得10
7秒前
江海不系舟完成签到 ,获得积分10
7秒前
12345发布了新的文献求助10
7秒前
7秒前
领导范儿的应助被科研通管家采纳,获得30
7秒前
英俊的铭的应助被科研通管家采纳,获得10
7秒前
科目三的应助被科研通管家采纳,获得10
8秒前
8秒前
Lucas的应助被艰辛岁月采纳,获得10
8秒前
FashionBoy的应助被科研通管家采纳,获得10
8秒前
时淮靖的应助被科研通管家采纳,获得60
8秒前
8秒前
天天快乐的应助被科研通管家采纳,获得10
8秒前
马轩发布了新的文献求助10
8秒前
Ruins发布了新的文献求助10
8秒前
SciGPT的应助被科研通管家采纳,获得10
8秒前
陌笙完成签到,获得积分20
8秒前
8秒前
8秒前
8秒前
9秒前
9秒前
归期完成签到,获得积分10
9秒前
呼呼呼呼发布了新的文献求助10
9秒前
9秒前
aa的应助被科研通管家采纳,获得10
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8164237
求助须知:如何正确求助?哪些是违规求助? 9558173
关于积分的说明 21743983
捐赠科研通 7754808
什么是DOI,文献DOI怎么找? 3428486
关于科研通互助平台的介绍 2553090
邀请新用户注册赠送积分活动 2473110